PMID- 37473999 OWN - NLM STAT- MEDLINE DCOM- 20230807 LR - 20230807 IS - 1873-7064 (Electronic) IS - 0028-3908 (Linking) VI - 238 DP - 2023 Nov 1 TI - MPFC PV(+) interneurons are involved in the antidepressant effects of running exercise but not fluoxetine therapy. PG - 109669 LID - S0028-3908(23)00259-9 [pii] LID - 10.1016/j.neuropharm.2023.109669 [doi] AB - Depression is a complex psychiatric disorder. Previous studies have shown that running exercise reverses depression-like behavior faster and more effectively than fluoxetine therapy. GABAergic interneurons, including the PV(+) interneuron subtype, in the medial prefrontal cortex (MPFC) are involved in pathological changes of depression. It was unknown whether running exercise and fluoxetine therapy reverse depression-like behavior via GABAergic interneurons or the PV(+) interneurons subtype in MPFC. To address this issue, we subjected mice with chronic unpredictable stress (CUS) to a 4-week running exercise or fluoxetine therapy. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that running exercise enriched GABAergic synaptic pathways in the MPFC of CUS-exposed mice. However, the number of PV(+) interneurons but not the total number of GABAergic interneurons in the MPFC of CUS-exposed mice reversed by running exercise, not fluoxetine therapy. Running exercise increased the relative gene expression levels of the PV gene in the MPFC of CUS-exposed mice without altering other subtypes of GABAergic interneurons. Moreover, running exercise and fluoxetine therapy both significantly improved the length, area and volume of dendrites and the spine morphology of PV(+) interneurons in the MPFC of mice exposed to CUS. However, running exercise but not fluoxetine therapy improved the dendritic complexity level of PV(+) interneurons in the MPFC of CUS-exposed mice. In summary, the number and dendritic complexity level of PV(+) interneurons may be important therapeutic targets for the mechanism by which running exercise reverses depression-like behavior faster and more effectively than fluoxetine therapy. CI - Copyright (c) 2023 Elsevier Ltd. All rights reserved. FAU - Qin, Lu AU - Qin L AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Liang, Xin AU - Liang X AD - Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Department of Pathology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Qi, Yingqiang AU - Qi Y AD - Institute of Life Science, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Luo, Yanmin AU - Luo Y AD - Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Department of Physiology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Xiao, Qian AU - Xiao Q AD - Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Department of Radioactive Medicine, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Huang, Dujuan AU - Huang D AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Zhou, Chunni AU - Zhou C AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Jiang, Lin AU - Jiang L AD - Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Lab Teaching & Management Center, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Zhou, Mei AU - Zhou M AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Zhou, Yuning AU - Zhou Y AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. FAU - Tang, Jing AU - Tang J AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. Electronic address: 710345845@qq.com. FAU - Tang, Yong AU - Tang Y AD - Department of Histology and Embryology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Stem Cells and Tissue Engineering, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, PR China. Electronic address: ytang062@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230719 PL - England TA - Neuropharmacology JT - Neuropharmacology JID - 0236217 RN - 01K63SUP8D (Fluoxetine) RN - 0 (Antidepressive Agents) SB - IM MH - Mice MH - Animals MH - *Fluoxetine/pharmacology/metabolism MH - Antidepressive Agents/pharmacology MH - Interneurons MH - Prefrontal Cortex MH - *Running OTO - NOTNLM OT - Dendrite OT - Depression OT - Exercise OT - MPFC OT - PV(+) interneurons OT - Stereology COIS- Declaration of competing interest The authors declare no conflicts of commercial or financial relationships. EDAT- 2023/07/21 01:12 MHDA- 2023/08/07 06:42 CRDT- 2023/07/20 19:27 PHST- 2023/04/06 00:00 [received] PHST- 2023/07/14 00:00 [revised] PHST- 2023/07/17 00:00 [accepted] PHST- 2023/08/07 06:42 [medline] PHST- 2023/07/21 01:12 [pubmed] PHST- 2023/07/20 19:27 [entrez] AID - S0028-3908(23)00259-9 [pii] AID - 10.1016/j.neuropharm.2023.109669 [doi] PST - ppublish SO - Neuropharmacology. 2023 Nov 1;238:109669. doi: 10.1016/j.neuropharm.2023.109669. Epub 2023 Jul 19.